BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17290279)

  • 1. Chronic kidney disease in long-term survivors of hematopoietic cell transplant.
    Hingorani S; Guthrie KA; Schoch G; Weiss NS; McDonald GB
    Bone Marrow Transplant; 2007 Feb; 39(4):223-9. PubMed ID: 17290279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary elafin and kidney injury in hematopoietic cell transplant recipients.
    Hingorani S; Finn LS; Pao E; Lawler R; Schoch G; McDonald GB; Najafian B; Sandmaier B; Gooley T
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):12-20. PubMed ID: 25388519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
    Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GVHD-associated chronic kidney disease after allogeneic haematopoietic cell transplantation.
    Sakellari I; Barbouti A; Bamichas G; Mallouri D; Kaloyannidis P; Fragidis S; Batsis I; Apostolou C; Karpouza A; Yannaki E; Smias C; Sombolos K; Anagnostopoulos A
    Bone Marrow Transplant; 2013 Oct; 48(10):1329-34. PubMed ID: 23584436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute.
    Jo T; Arai Y; Kondo T; Kitano T; Hishizawa M; Yamashita K; Takaori-Kondo A
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2159-2165. PubMed ID: 28822830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors.
    Hingorani SR; Guthrie K; Batchelder A; Schoch G; Aboulhosn N; Manchion J; McDonald GB
    Kidney Int; 2005 Jan; 67(1):272-7. PubMed ID: 15610251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Glomerular Filtration Rate and Impact on Long-Term Survival among Adults after Hematopoietic Cell Transplantation: A Prospective Cohort Study.
    Hingorani S; Pao E; Stevenson P; Schoch G; Laskin BL; Gooley T; McDonald GB
    Clin J Am Soc Nephrol; 2018 Jun; 13(6):866-873. PubMed ID: 29669818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; SociƩ G; Peraldi MN
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].
    Zhou T; Cen XN; Qiu ZX; Ou JP; Wang WS; Xu WL; Li Y; Wang MJ; Wang LH; Tong YJ; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):723-8. PubMed ID: 19549395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
    Friedman DN; Hilden P; Moskowitz CS; Suzuki M; Boulad F; Kernan NA; Wolden SL; Oeffinger KC; Sklar CA
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):475-482. PubMed ID: 28040534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
    Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrolithiasis in pediatric hematopoietic cell transplantation with up to 40 years of follow-up.
    Hoffmeister PA; Storer BE; Baker KS; Hingorani SR
    Pediatr Blood Cancer; 2014 Mar; 61(3):417-23. PubMed ID: 24038785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes.
    Saddadi F; Hakemi M; Najafi I; Moghadam K; Ghavamzadeh A; Jahani M; Ganji M; Amini M; Soleimanian T
    Transplant Proc; 2009 Sep; 41(7):2895-7. PubMed ID: 19765466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.
    Zhou W; Sultana R; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh LP; Koh M; Loh Y; Tan P; Linn YC
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT.
    Shimoi T; Ando M; Munakata W; Kobayashi T; Kakihana K; Ohashi K; Akiyama H; Sakamaki H
    Bone Marrow Transplant; 2013 Jan; 48(1):80-4. PubMed ID: 22635246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Kidney Morbidity and Mortality in Hematopoietic Cell Transplant Survivors.
    Wu NL; Hingorani S; Cushing-Haugen KL; Lee SJ; Chow EJ
    Transplant Cell Ther; 2021 May; 27(5):434.e1-434.e6. PubMed ID: 33775588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study.
    Hirano D; Kakegawa D; Miwa S; Umeda C; Takemasa Y; Tokunaga A; Kawakami Y; Ito A
    BMC Nephrol; 2020 Aug; 21(1):373. PubMed ID: 32854640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients.
    Garnica M; da Cunha MO; Portugal R; Maiolino A; Colombo AL; Nucci M
    Clin Infect Dis; 2015 Mar; 60(6):875-80. PubMed ID: 25425628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.